Open AccessThe use of the Chuang′s prognostic scale to predict the survival of metastatic colorectal cancer patients receiving palliative systemic anticancer therapy
Author(s) -
Samy A. Alsirafy,
Omar Zaki,
Amr Sakr,
Dina E. Farag,
Wessam A. El-Sherief,
Abha A Mohammed
Publication year - 2016
Publication title -
indian journal of palliative care/indian journal of palliative care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 26
eISSN - 1998-3735
pISSN - 0973-1075
DOI - 10.4103/0973-1075.185043
Subject(s) - medicine , colorectal cancer , confidence interval , oncology , palliative care , cancer , ascites , performance status , nursing
With the increasing number of agents active against cancer, advanced cancer patients including metastatic colorectal cancer (mCRC) patients may continue receiving palliative systemic anticancer therapy (PSAT) near the end-of-life. Validated palliative prognostic models, such as the Chuang's prognostic scale (CPS), may be helpful in identifying mCRC patients with limited survival who are unlikely to benefit from PSAT.